Literature DB >> 12679701

Differences in prescription of antiretroviral therapy in a large cohort of HIV-infected patients.

A D McNaghten1, Debra L Hanson, Mark S Dworkin, Jeffrey L Jones.   

Abstract

The objective of this study was to determine factors associated with prescription of highly active antiretroviral therapy (HAART). The authors observed 9530 patients eligible for antiretroviral therapy (ART) in more than 100 hospitals and clinics in 10 US cities. Multiple logistic regression analysis was used to assess factors associated with HAART prescription, stratifying patients by no history versus history of ART to assess the association between prescription and CD4, viral load, and outpatient visits. Overall, female gender (odds ratio [OR], 0.68; 95% confidence interval [CI], 0.60-0.76) and alcoholism (OR, 0.85; 95% CI, 0.74-0.99) were associated with decreased likelihood of HAART prescription. Enrollment at a private facility (OR, 1.33; 95% CI, 1.14-1.56), heterosexual exposure (OR, 1.34; 95% CI, 1.13-1.58), and Hispanic ethnicity (OR, 1.19; 95% CI, 1.04-1.37) were associated with prescription. For patients with no history of prescribed ART, CD4 <500 cells/microL (OR, 3.94; 95% CI, 2.02-7.66), and high viral load were associated with increased likelihood of prescription; for patients with history of ART prescription, those whose outpatient visits averaged > or =2 per 6-month interval (OR, 1.30; 95% CI, 1.10-1.54) were more likely and those with high viral load were less likely to be prescribed HAART (OR, 0.50; 95% CI, 0.44-0.56). The authors found differences in HAART prescription by gender, race, exposure mode, alcoholism, and provider type for all patients, by CD4 and viral load for patients with no history of ART prescription, and by average number of outpatient visits and viral load for patients with history of ART prescription.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12679701     DOI: 10.1097/00126334-200304150-00006

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  27 in total

1.  Crack cocaine use and adherence to antiretroviral treatment among HIV-infected black women.

Authors:  Tanya Telfair Sharpe; Lisa M Lee; Allyn K Nakashima; Laurie D Elam-Evans; Patricia L Fleming
Journal:  J Community Health       Date:  2004-04

2.  CCR5 expression is reduced in lymph nodes of HIV type 1-infected women, compared with men, but does not mediate sex-based differences in viral loads.

Authors:  Amie L Meditz; Joy M Folkvord; Ngan H Lyle; Kristina Searls; Yolanda S Lie; Eoin P Coakley; Martin McCarter; Samantha Mawhinney; Elizabeth Connick
Journal:  J Infect Dis       Date:  2013-10-31       Impact factor: 5.226

3.  Correlates of viral suppression among HIV-infected men who have sex with men and transgender women in Lima, Peru.

Authors:  Katherine M Rich; Javier Valencia Huamaní; Sara N Kiani; Robinson Cabello; Paul Elish; Jorge Florez Arce; Lia N Pizzicato; Jaime Soria; Jeffrey A Wickersham; Jorge Sanchez; Frederick L Altice
Journal:  AIDS Care       Date:  2018-05-30

4.  Influence of gender on receipt of guideline-based antiretroviral therapy in the era of HAART.

Authors:  Jennifer M Cocohoba; Keri N Althoff; Rebecca Godfrey; Frank J Palella; Ruth M Greenblatt
Journal:  AIDS Care       Date:  2011-07-06

5.  High levels of antiretroviral use and viral suppression among persons in HIV care in the United States, 2010.

Authors:  Julia C Dombrowski; Mari M Kitahata; Stephen E Van Rompaey; Heidi M Crane; Michael J Mugavero; Joseph J Eron; Stephen L Boswell; Benigno Rodriguez; W Christopher Mathews; Jeffrey N Martin; Richard D Moore; Matthew R Golden
Journal:  J Acquir Immune Defic Syndr       Date:  2013-07-01       Impact factor: 3.731

6.  HIV providers' perceptions of and attitudes toward female versus male patients.

Authors:  Oni J Blackstock; Mary Catherine Beach; P Todd Korthuis; Jonathan A Cohn; Victoria L Sharp; Richard D Moore; Somnath Saha
Journal:  AIDS Patient Care STDS       Date:  2012-09-14       Impact factor: 5.078

7.  Alcohol use disorders negatively influence antiretroviral medication adherence among men who have sex with men in Peru.

Authors:  Enrico G Ferro; Damian Weikum; Panagiotis Vagenas; Michael M Copenhaver; Pedro Gonzales; Jesus Peinado; Robinson Cabello; Javier R Lama; Jorge Sanchez; Frederick L Altice
Journal:  AIDS Care       Date:  2014-10-03

8.  Sex and Racial/Ethnic Differences in Premature Mortality Due to HIV: Florida, 2000-2009.

Authors:  Mary Jo Trepka; Theophile Niyonsenga; Kristopher P Fennie; Karma McKelvey; Spencer Lieb; Lorene M Maddox
Journal:  Public Health Rep       Date:  2015 Sep-Oct       Impact factor: 2.792

9.  Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy.

Authors:  Elena Losina; Bruce R Schackman; Sara N Sadownik; Kelly A Gebo; Rochelle P Walensky; John J Chiosi; Milton C Weinstein; Perrin L Hicks; Wendy H Aaronson; Richard D Moore; A David Paltiel; Kenneth A Freedberg
Journal:  Clin Infect Dis       Date:  2009-11-15       Impact factor: 9.079

10.  Alcohol use, depressive symptoms and the receipt of antiretroviral therapy in southwest Uganda.

Authors:  Priscilla Martinez; Irene Andia; Nneka Emenyonu; Judith A Hahn; Edvard Hauff; Larry Pepper; David R Bangsberg
Journal:  AIDS Behav       Date:  2007-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.